Mackenzie Financial’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Mackenzie Financial’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,876	Closed	-$2.37M	–	1497
2021 Q2	$2.37M	Sell	12,876 -3,709	-22%	-$681K	﹤0.01%	691
2021 Q1	$2.54M	Buy	16,585 +3,971	+31%	+$607K	﹤0.01%	647
2020 Q4	$1.97M	Sell	12,614 -6,680	-35%	-$1.04M	﹤0.01%	609
2020 Q3	$2.21M	Sell	19,294 -1,353	-7%	-$155K	0.01%	539
2020 Q2	$2.32M	Buy	20,647 +15,307	+287%	+$1.72M	0.01%	525
2020 Q1	$479K	Buy	5,340 +1,475	+38%	+$132K	﹤0.01%	802
2019 Q4	$418K	Buy	+3,865	New	+$418K	﹤0.01%	891
2018 Q4	–	Sell	-1,867	Closed	-$260K	–	1275
2018 Q3	$260K	Sell	1,867 -2,594	-58%	-$361K	﹤0.01%	1018
2018 Q2	$554K	Buy	4,461 +152	+4%	+$18.9K	﹤0.01%	767
2018 Q1	$480K	Buy	4,309 +1,159	+37%	+$129K	﹤0.01%	745
2017 Q4	$377K	Buy	3,150 +1,072	+52%	+$128K	﹤0.01%	722
2017 Q3	$292K	Buy	+2,078	New	+$292K	﹤0.01%	562
2017 Q1	–	Sell	-39,900	Closed	-$4.88M	–	714
2016 Q4	$4.88M	Buy	+39,900	New	+$4.88M	0.03%	279
2016 Q3	–	Sell	-100,735	Closed	-$11.8M	–	881
2016 Q2	$11.8M	Sell	100,735 -12,447	-11%	-$1.45M	0.07%	236
2016 Q1	$15.8M	Buy	113,182 +89	+0.1%	+$12.4K	0.14%	160
2015 Q4	$21.6M	Buy	113,093 +909	+0.8%	+$173K	0.13%	156
2015 Q3	$17.5M	Sell	112,184 -16,116	-13%	-$2.52M	0.11%	185
2015 Q2	$23.2M	Buy	128,300 +29,870	+30%	+$5.4M	0.13%	170
2015 Q1	$17.1M	Buy	98,430 +270	+0.3%	+$46.8K	0.09%	204
2014 Q4	$18.2M	Sell	98,160 -33,110	-25%	-$6.13M	0.09%	179
2014 Q3	$21.8M	Sell	131,270 -2,650	-2%	-$439K	0.11%	171
2014 Q2	$20.9M	Sell	133,920 -1,820	-1%	-$284K	0.1%	190
2014 Q1	$20.7M	Sell	135,740 -9,330	-6%	-$1.42M	0.1%	182
2013 Q4	$19.3M	Buy	145,070 +6,020	+4%	+$800K	0.1%	189
2013 Q3	$16.2M	Sell	139,050 -15,000	-10%	-$1.74M	0.08%	204
2013 Q2	$14.2M	Buy	+154,050	New	+$14.2M	0.07%	221